Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: Decreased levels in Alzheimer's disease

Molecular Brain Research

Volumn 76, Issue 2, 2000, Pages 347-354

  Holsinger, R M Dalmian ^a   Schnarr, Jane ^a   Henry, Pauline ^a   Castelo, Vivian T ^b   Fahnestock, Margaret ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Basal forebrain; Brain derived neurotrophic factor; Cholinergic; Human postmortem; Neurodegeneration; Neurotrophic factor

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN TISSUE; CONTROLLED STUDY; FEMALE; FOREBRAIN; HUMAN; HUMAN TISSUE; MALE; PARIETAL LOBE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTINS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PARIETAL LOBE; REFERENCE VALUES; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0034728595     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(00)00023-1     Document Type: Article

References (41)

1. R.F. Alderson, A.L. Alterman, Y. Barde, R.M. Lindsay, Brain-derived neurotrophic factor increases survival and differentiated function of rat septal cholinergic neurons in culture, Neuron 5 (1990) 297-306.
2. D.G. Amaral, W.M. Cowan, Subcortical afferents to the hippocampal formation in the monkey, J. Comp. Neurol. 189 (1980) 573-591.
3. L.L. Boatell, N. Lindefors, M. Ballarin, P. Ernfors, N. Mahy, H. Persson, Activation of basal forebrain cholinergic neurons differentially regulates brain-derived neurotrophic factor mRNA expression in different projection areas, Neurosci. Lett. 136 (1992) 203-208.
4. B. Connor, D. Young, Q. Yan, R.I.M. Faull, B. Synek, M. Dragunow, Brain-derived neurotrophic factor is reduced in Alzheimer's disease, Mol. Brain Res. 49 (1997) 71-81.
5. J.T. Coyle, D.L. Price, M.R. DeLong, Alzheimer's disease: a disorder of cortical cholinergic innervation, Science 219 (1983) 1184-1190.
6. A.C. Cuello, M.V. Sofroniew, The anatomy of the CNS cholinergic neurons, Trends Neurosci. 7 (1984) 74-78.
7. M.M. Dugich-Djordjevic, C. Peterson, F. Isono, H.R. Widmer, T.L. Denton, G.L. Bennett, F. Hefti, Immunohistochemical visualization of brain-derived neurotrophic factor in the rat brain, Eur. J. Neurosci. 7 (1995) 1831-1839.
8. P. Ernfors, C.F. Ibanez, T. Ebendal, L. Olson, H. Persson, Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain, Proc. Natl. Acad. Sci., U.S.A. 87 (1990) 5454-5458.
9. P. Etienne, Y. Robitaille, P. Wood, S. Gauthier, N.P.V. Nair, R. Quirion, Nucleus basalis neuronal loss, neuritic plaque and acetyl-transferase activity in advanced Alzheimer's disease, Neuroscience 19 (1986) 1279-1291.
10. I. Ferrer, C. Marin, M.J. Rey, T. Ribalta, E. Goutan, R. Blanco, E. Tolosa, E. Martí, BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies, J. Neuropathol. Exp. Neurol. 58 (1999) 729-739.
11. W.J. Fnedman, C.F. Ibanez, F. Halbook, H. Persson, L.D. Cain, C.F. Dreyfus, I.B. Black, Differential actions of neurotrophins in the locus coeruleus and basal forebrain, Exp. Neurol. 119 (1993) 72-78.
12. W.C. Gause, J. Adamovicz, The use of the PCR to quantitate gene expression, PCR Methods Appl. 3 (1994) S123-S130.
13. M. Goedert, A. Fine, S.P. Hunt, A. Ulrich, Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease, Mol. Brain Res. 1 (1986) 85-92.
14. F. Hefti, Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections, J. Neurosci. 6 (1986) 2155-2162.
15. F. Hefti, W.J. Weiner, Nerve growth factor and Alzheimer's disease, Ann. Neurol. 20 (1986) 275-281.
16. C.E. Henderson, E. Bloch-Galego, W. Camu, A. Gouin, C. Lemeulle, C. Mettling, Motoneuron survival factors: biological roles and therapeutic potential, Neuromuscular Disord. 3 (1993) 455-458.
17. C. Hock, K. Heese, F. Müller-Spahn, C. Hulette, C. Rosenberg, U. Otten, Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease, Neurosci. Lett. 241 (1998) 151-154.
18. M. Hofer, S.R. Pagliusi, A. Hohn, J. Leibrock, Y.-A. Barde, Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain, EMBO J. 9 (1990) 2459-2464.
19. C. Hyman, M. Hofer, Y.-A. Barde, M. Juhasz, S. Squinto, R.M. Lindsay, BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra, Nature 350 (1991) 230-232.
20. J.E. Johnson, Y.-A. Barde, M. Schwab, H. Thoenen, Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells, J. Neurosci. 6 (1986) 3031-3038.
21. M. Knipper, M. da Penha Berzaghi, A. Blochl, H. Breer, H. Thoenen, D. Lindholm, Positive feedback between acetylcholine and the neurotrophins nerve growth factor and brain-derived neurotrophic factor in the rat hippocampus, Eur. J. Neurosci. 6 (1994) 668-671.
22. B. Knusel, K.D. Beck, J.W. Winslow, A. Rosenthal, L.E. Burton, H.R. Widmier, K. Nikolics, F. Hefti, Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain, J. Neurosci. 12 (1992) 4391-4402.
23. P.A. Lapchak, D.M. Araujo, F. Hefti, Cholinergic regulation of hippocampal brain-derived neurotrophic factor mRNA expression: evidence from lesion and chronic cholinergic drug treatment studies, Neuroscience 52 (1993) 575-585.
24. R.M. Lindsay, H. Rohrer, Placodal sensory neurons in cultured nodose ganglion neurons are unresponsive to NGF, lack NGF receptors but are supported by a liver-derived neurotrophic factor, Dev. Biol. 112 (1985) 30-48.
25. P.C. Maisonpierre, L. Belluscio, S. Squinto, N.Y. Ip, M.E. Furth, R.M. Lindsay, G.D. Yancopoulos, Neurotrophin-3 : a neurotrophic factor related to NGF and BDNF, Science 247 (1990) 1146-1451.
26. P.C. Maisonpierre, M.M. Le Beau, R. Espmosa III, N.Y. Ip, L. Belluscio, S.M. De La Monte, S. Squinto, M.E. Furth, G.D. Yancopoulos, Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations, Genomics 10 (1991) 558-568.
27. L.M. Maness, A.J. Kastin, J.T. Webber, W.A. Banks, B.S. Beckman, J.E. Zadina, The neurotrophins and their receptors: structure, function and neuropathology, Neurosci. Biobehav. Rev. 18 (1994) 143-159.
28. D.M. Mann, Is the pattern of nerve cell loss in aging and Alzheimer's disease real, or only apparent?, Neurobiol. Aging 12 (1991) 340-343.
29. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, E. Stadlan, Clinical diagnosis of Alzheimer's disease: report of NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Service Task Force on Alzheimer's disease, Neurology 34 (1984) 939-944.
30. M. McKinney, J.T. Coyle, J.C. Hedreen, Topographic analysis of the innervation of the rat neocortex and hippocampus by the basal forebrain cholinergic system, J. Comp. Neurol. 217 (1983) 103-121.
31. E.J. Mufson, J.S. Kroin, T.J. Sendera, T. Sobreviela, Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases, Prog. Neurobiol. 57 (1999) 451-484.
32. K.D. Murray, C.M. Gall, E.G. Jones, P.J. Isackson, Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease, Neuroscience 60 (1994) 37-48.
33. M. Narisawa-Saito, K. Wakabayashi, S. Tsuji, H. Takahashi, H. Nawa, Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease, NeuroReport 7 (1996) 2925-2928.
34. H.S. Phillips, J.M. Hains, G.R. Laramee, A. Rosenthal, J.W. Winslow, Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons, Science 250 (1990) 290-293.
35. H.S. Phillips, J.M. Hains, M. Armanini, G.R. Laramee, S.A. Johnson, J.W. Winslow, BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease, Neuron 7 (1991) 695-702.
36. R.J. Rylett, L.R. Williams, Role of neurotrophins in cholinergic-neurone function in the adult and aged CNS, Trends Neurosci. 17 (1994) 486-490.
37. D. St. Amand, C. Pottage, P. Henry, M. Fahnestock, Method for quantification of low-abundance nerve growth factor mRNA expression in human nervous tissue using competitive reverse transcription polymerase chain reaction, DNA Cell Biol. 15 (1996) 415-422.
38. M. Takeda, T. Nishimura, S. Hariguchi, Y. Tatebayashi, T. Tanaka, S. Tanimukai, K. Tada, Study of cytoskeletal proteins in fibroblasts cultured from familial Alzheimer's disease, Acta Neurol. Scand. 84 (1991) 416-420.
39. M. Takeda, Y. Tatebayashi, T. Nishimura, Change in the cytoskeletal system in fibroblasts from patients with familial Alzheimer's disease, Prog. Neuropsychopharmacol. Biol. Psychiatry 16 (1992) 317-328.
40. C. Wetmore, P. Ernfors, H. Persson, L. Olson, Localization of brain-derived neurotrophic factor mRNA to neurons in the brain by in situ hybridization, Exp. Neurol. 109 (1990) 141-152.
41. P.J. Whitehouse, D.L. Price, R.G. Struble, A.W. Clark, J.T. Coyle, M.R. DeLong, Alzheimer's disease and senile dementia; loss of neurons in the basal forebrain, Science 215 (1982) 1237-1239.